Center for Evolutionary Medicine and Informatics, Arizona State University, Tempe, Arizona, 85287-5301.
Protein Sci. 2013 Oct;22(10):1392-8. doi: 10.1002/pro.2325. Epub 2013 Sep 4.
Many applications in biotechnology require human proteins generated from human cells. Stable cell lines commonly used for this purpose are difficult to develop, and scaling to large numbers of proteins can be problematic. Transient expression can circumvent this problem, but protein yields are generally too low for most applications. Here we report a novel 37-nucleotide leader sequence that promotes rapid and high transgene expression in mammalian cells. This sequence was identified by in vitro selection and functions in a transient vaccinia-based cytoplasmic expression system. Vectors containing this sequence produce microgram levels of protein in just 6 h from a small-scale expression in 10(6) cells. This level of protein synthesis is ideal for high throughput production of human proteins, and could be scaled to generate milligram quantities of protein. The technology is compatible with a broad range of cell lines, accepts plasmid and linear DNA, and functions with viruses that are approved for use under BSL1 conditions. We suggest that these advantages provide a powerful method for generating human protein in mammalian cells.
许多生物技术应用都需要从人体细胞中生成的人类蛋白质。为此目的而常用的稳定细胞系难以开发,并且大规模生产蛋白质可能会出现问题。瞬时表达可以规避此问题,但对于大多数应用而言,蛋白质产量通常太低。在这里,我们报告了一种新颖的 37 个核苷酸的前导序列,可促进哺乳动物细胞中快速和高效的转基因表达。该序列通过体外选择鉴定,并在基于瞬时痘苗的细胞质表达系统中发挥作用。包含该序列的载体在小规模表达 10^6 个细胞 6 小时后即可产生微克水平的蛋白质。这种蛋白质合成水平非常适合高通量生产人类蛋白质,并且可以扩展到产生毫克级别的蛋白质。该技术与广泛的细胞系兼容,可接受质粒和线性 DNA,并与在 BSL1 条件下批准使用的病毒兼容。我们认为,这些优势为在哺乳动物细胞中生成人类蛋白质提供了一种强大的方法。